Oppenheimer says it expects sales of Cubist's (CBST -2.7%) Cubicin to surpass expectations this...


Oppenheimer says it expects sales of Cubist's (CBST -2.7%) Cubicin to surpass expectations this year, and the firm thinks that the company's current 2012 guidance may be too conservative. It raises its price target to $49 from $45 and maintains an Outperform rating.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs